Product information

Current status:

Cancelled Post Market

Current status date:

1999-08-12

Original market date: ^{See footnote 1}

1995-12-31

Product name:

KABIKINASE - PWS 250000 UNIT/VIAL

DIN:

02126125 Electronic product monograph is not available

Company:

PHARMACIA & UPJOHN INC
1200 55 Standish Court
Mississauga
Ontario
Canada L5R 4E3

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous ,  Intracoronary

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.20 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AD01 STREPTOKINASE

Active ingredient group (AIG) number:^{See footnote5}

0107605001